Published in Patient Care Law Weekly, May 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Quest Diagnostics.
Report 1: Quest Diagnostics Incorporated (DGX) announced that for the fourth quarter income from continuing operations was $151 million, or $0.77 per diluted share compared to $149 million, or $0.73 per diluted share for the prior year.
Fourth quarter revenues from continuing operations grew 8.5% over the prior year level to $1.5 billion. The acquisitions of LabOne, which was completed on November 1, 2005, and Focus Diagnostics, which was completed on July 1,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly